The pharmaceutical company Eli Lilly is planning to invest more than $6 billion in a new manufacturing facility that is expected to bring 3,450 manufacturing and construction jobs.
The facility is being built in Huntsville, Alabama, the company announced in a statement on Dec. 9 , and will produce small molecule synthetic and peptide medicines.
"Some of our biggest medicines will come here," Lilly CEO David A. Ricks said in Huntsville according to Business Alabama . "Those are GLP-1 weight-loss medications that are also being studied in all manner of other diseases – heart disease, inflammation and even brain diseases, addiction… These drugs are transforming not just metabolic conditions, but so many others, and we'll export those around the world. We'll make them here and ship them to the plant."
The company intends on bringing 450 jobs to Huntsville, including engineers, scientists, operations personnel and lab technicians.
Construction, which is set to begin in 2026, is anticipated to generate 3,000 construction jobs while the facility is being built. Eli Lilly predicts that construction will be completed in 2032.
"Huntsville's track record of science and innovation, supported by advanced manufacturing expertise and a skilled workforce, makes Alabama an ideal location for Lilly to expand domestic manufacturing capacity for next‑generation medicines," Eli Lilly Chair and CEO David Ricks said in a statement. "Today's investment continues the onshoring of active pharmaceutical ingredient (API) production, strengthening supply chain resilience and reliable access to medicines for patients in the U.S."
In a statement, Governor of Alabama Kay Ivey called the estimated $6 billion project "the largest initial investment in our state's history" adding that "we will ensure this great company achieves their mission of improving the health and well-being of people all across the country and globe."
Huntsville's site was picked after Eli Lilly was considering some 300 proposals from around the country, the statement reads.
Earlier this year, Eli Lilly announced plans to bolster its domestic medicine production and revealed plans to build sites in Texas and Virginia while expanding an existing manufacturing site in Puerto Rico.
Another U.S. location will be announced in the coming weeks, the company said.
More Business News
-
The most promising startups from Techstars Boston's latest batch
-
Australian maker of compressed-straw wall and ceiling panels eyes Springfield
-
Amherst Cinema offering black-and-white classics for the holidays
-
Major data breach involving Mass.' largest health insurer exposes Social Security numbers
Read the original article on MassLive . Add MassLive as a Preferred Source by clicking here .
